title: [Early detection or screening in the prevention of prostate cancer?]
abstract: Prostate cancer (PC) is the most common malignancy in men in the developed world and the second leading cause of cancer death in men in the USA, behind lung cancer. In Europe, it is the third leading cause of cancer death in men (after lung and colorectal cancers). The role of PC screening is currently being questioned. The following article summarises the most relevant epidemiological aspects of PC, as well as major clinical trials of PC screening, and recommendations of the various medical scientific associations on whether or not to screen for PC.
authors.affiliation: Centro de Salud Llefiá, Badalona (Barcelona), España; Grupo de Trabajo de Nefrourología SEMERGEN, España.
authors.forename: F J
authors.initials: FJ
authors.lastname: Brenes Bermúdez
authors.affiliation: Centro de Salud José María Álvarez, Don Benito (Badajoz), España; Grupo de Trabajo de Nefrourología SEMERGEN, España. Electronic address: a.alcantara.montero@hotmail.com.
authors.forename: A
authors.initials: A
authors.lastname: Alcántara Montero
mesh_terms: D055088:Early Detection of Cancer / Q000379:methods*; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control
keywords: Baseline PSA; Cribado; Cáncer de próstata; Diagnóstico precoz; Digital rectal examination; Early diagnosis; PSA basal; Prostate cancer; Screening; Tacto rectal